biopharmacy 中文意思是什麼
biopharmacy
解釋
生物藥劑學-
Acoording to company valuation theory, based on ananlysis and comparison of present company valuation model and valuation technology, combining characteristics of biopharmacy company of high technology, high risk, high profits, i take sichuan dikang science and technology pharmacy, a biomedical listing company for dcfm model value ' s valuation. through analysing dikang ' s past achievements and value - driving business, i made
本文根據公司價值的有關理論，對目前運用的公司價值評估模型和評估技術的進行分析和比較基礎上，結合生物制藥上市公司高技術、高風險、高收益等高新技術企業特點，選擇貼現現金流模型對物制藥上市公司? ?四川迪康科技藥業股份有限公司的價值進行評估。 -
A few years passed, what is the performance of the companies which have invested the biopharmacy industry
幾年過去了，這些投資生物制藥的公司經營業績到底如何 -
Our country regards the biopharmacy industry as the emphasis and strategic target of the scientific technology development
我國已明確地將生物制藥產業作為21世紀科技發展的重點和戰略目標。 -
However, some listing corporations do not achieve outstanding achievements. biopharmacy companies are faced with both huge developing potential and risks
生物制藥上市公司企業面臨著巨大的發展潛力，同時也承受著極大的風險。 -
Chapter four is the emphasis of this dissertation, it focuses on the result of the performance evaluation of the biopharmacy public companies
第四章是本文的重點，主要介紹本文的實證結果，以及生物制藥上市公司經營業績評價結果。 -
Since 1999, many companies in our country started to go into the biopharmacy field by all kinds of forms, and invested the biopharmacy industry during the two years of 1997 - 1998
自1992年起，我國許多公司就開始以各種形式介入生物制藥領域，並在1997 - 1998兩年，形成了轟轟烈烈的投資生物制藥的高潮。 -
In this dissertation, i will select the excellent public companies which represent the biopharmacy industry as the study target, use the factor analysis method based on finance measures to evaluate the public companies of the biopharmacy industry
本文將把代表生物制藥行業的優秀上市公司作為研究對象，採用以財務指標為基礎的因子分析方法來綜合評價生物制藥上市公司的經營業績。 -
The topic of the first chapter is mainly to introduce the concept and the character of the biopharmacy, the development outline of the biopharmacy industry in our civil country and outside of our country and the public companies outline of the biopharmacy industry in our country
本文共分五章。第一章主要介紹生物制藥的概念和特點、國內外生物制藥行業發展概況以及我國生物制藥上市公司概況。 -
Biopharmacy industry, as one of the four high technology industries in the 21 century, is rewarded as " the morning sun industry " and " the gold industry " for its great scientific research value, obvious economy yield, high growth speed and wide development perspective. government, high technology field and enterprise field all pay high attention to it and support it greatly
生物制藥行業作為21世紀四大高科技產業之一，因其巨大的科研價值、顯著的經濟和社會效益、高速的成長性以及廣闊的發展前景而被譽為「朝陽產業」和「黃金產業」 ，各國政府、科技界和企業界都給予高度的重視和大力支持。
分享友人